---
title: "C4 Therapeutics (CCCC.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CCCC.US/norm.md"
symbol: "CCCC.US"
name: "C4 Therapeutics"
parent: "https://longbridge.com/en/quote/CCCC.US.md"
datetime: "2026-05-19T22:33:41.717Z"
locales:
  - [en](https://longbridge.com/en/quote/CCCC.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CCCC.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CCCC.US/norm.md)
---

# C4 Therapeutics (CCCC.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2000 | -0.1754 | -0.4433 | -0.3664 | -0.3716 |
| ROE | -40.96% | -39.88% | -78.34% | -56.38% | -51.22% |
| Revenue | 6.15M | 11.02M | 11.23M | 6.46M | 7.24M |
| Net income | -25.13M | -20.49M | -32.17M | -26.02M | -26.32M |
| Operating income | -27.79M | -23.14M | -23.68M | -28.50M | -29.16M |
| Gross margin | 100.00% | 737.99% | -131.42% | -305.34% | -274.03% |
| Net margin | -408.47% | -185.97% | -286.43% | -402.60% | -363.66% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 328.86M | 359.07M | 265.49M | 296.53M | 319.52M |
| Leverage | 1.40 | 1.40 | 1.72 | 1.70 | 1.64 |
| BVPS | 2.25 | 2.65 | 2.08 | 2.45 | 2.75 |
| Turnover | 0.1075 | 0.1014 | 0.0939 | 0.1011 | 0.1108 |
| Cash & STI | 235.67M | 248.54M | 191.88M | 214.55M | 215.09M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 43.58M | 45.28M | 47.09M | 59.76M | 61.36M |
| Net debt | -209.82M | -237.12M | -138.30M | -160.05M | -170.34M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -29.94M | -22.14M | -31.21M | -12.06M | -33.28M |
| Investing CF | 16.15M | -80.73M | 4.09M | 38.92M | 29.13M |
| Financing CF | 462000.00 | 118.67M | 7.77M | 0.0000 | -46000.00 |
| Free CF | -23.09M | -7.70M | -23.62M | -1.63M | -21.35M |
| OCF coverage | -46787.50% | -201318.18% | -7592.94% | -6517.30% | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | -64000.00 | -11000.00 | -411000.00 | -185000.00 | - |